# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Nyxoah Announces First U.S. Commercial Patients Implanted with Genio SystemEarly Commercial Launch Demonstrates Strong Physicia...
Nyxoah Provides an Update on Expanded Middle East PresenceNew Centers in Dubai, Kuwait, and Abu Dhabi Following First Genio® Im...
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.Mont-Saint-Guibert, Belgium – September 15, 2025,...
Nyxoah (NASDAQ:NYXH) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of $(0.63) by 1.5...
U.S. stock futures were fluctuating on Monday after following Friday's advances. Futures of major benchmark indices were mi...